San Francisco startup Composition Therapeutics can be engaged on an oral, as soon as-every day GLP-one drug called GSBR-1290—the drug surpassed Wall Street’s expectations in June any time a mid-phase study confirmed regular weight loss of all-around 6% and it designs to start out A f